Yes, according the journal Neurology:
The authors caution that litigation’s effects could seriously impair efforts to identify compounds that contribute to a wide variety of diseases, including Parkinson’s disease, Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). They provide suggestions for policy changes to help shield scientists and their research. Recommendations include enhancing privacy protections for patient data obtained in research projects and eliminating financial conflicts-of-interest for scientists actively involved in research related to the litigation.
Related posts:
- HIPAA is impeding research this time
- LA Times on medical blogs
- When compassion meets progress in American health care
- Medical news briefs
- The Detroit Free Press on medical blogs
- My take: Slow medicine, destroying the medical home, animosity, patient communication
- A jury ignores findings from a pre-litigation screening panel
KevinMD.com on Facebook
{ 2 comments }
This isn’t news, just a restatement of the obvious. Litigation fears and burdensome regulation “protect” patients from innovations both good and bad. This is why much medical innovation is coming from the petri dishes of other countries. Absolute risk aversion equals stasis.
So because a researcher might have to explain his findings and answer to them when he might not want to, his progress is “slowed”?
Sleep slows medical progress. Golf slows medical progress. Talking to the wife slows medical progress. Let’s outlaw them.
Good stuff.
Comments on this entry are closed.